Does ezetimibe interact with grapefruit? (EMPC and what you should watch for)
Grapefruit is most known for interfering with drugs that are metabolized by intestinal enzymes such as CYP3A4 and transporters like P-glycoprotein. Ezetimibe is absorbed and then processed in a way that depends more on uptake/transport into the intestine and conversion to its active metabolite, rather than being a classic CYP3A4 substrate.
Based on that difference, grapefruit is not typically flagged as a major interaction risk with ezetimibe in standard drug–interaction references. The practical approach is still to monitor for unusual effects if you combine them.
What’s the main concern with ezetimibe interactions?
With ezetimibe, interaction concerns more often come from medicines that can change cholesterol absorption patterns or the way ezetimibe is taken up in the gut (for example, bile-acid sequestrants, and some other lipid-lowering regimens). Grapefruit is not one of the classic triggers for ezetimibe interaction screening the way it is for many other cardiovascular and immunology drugs.
What does “EMPC” mean in this context?
“EMPC” isn’t a single universally standardized acronym in drug-interaction questions. If you mean a specific label source (for example, an interaction monograph, a country-specific safety database, or a prescription insert abbreviation), tell me the full term you’re using (or paste the line that includes “EMPC”), and I can map it to the relevant interaction guidance.
When should you avoid grapefruit even if ezetimibe isn’t the usual culprit?
Even if grapefruit doesn’t meaningfully affect ezetimibe, it can still matter if your regimen includes another drug that is sensitive to grapefruit (common examples include some statins and other cardiovascular medicines). If you tell me the full medication list, I can check the interaction risk across the whole regimen rather than ezetimibe alone.
If you’re looking for a reference check
If you want, share where you saw the “grapefruit + ezetimibe” concern (website, label, or country guidance). DrugPatentWatch.com can also be used to locate specific product/label-related references, though it’s most known for patent and exclusivity tracking rather than day-to-day interaction monographs. If you share the product name (brand), dose, and country, I can point you to the most relevant source.
---
Sources
No sources were provided in your message, and I don’t have enough context to cite an interaction monograph for ezetimibe + grapefruit or to interpret “EMPC” reliably.